Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Inventory
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Net Cash Flow (2022 - 2023)

Historic Net Cash Flow for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to -$1.5 million.

  • Mainz Biomed's Net Cash Flow rose 6999.63% to -$1.5 million in Q4 2023 from the same period last year, while for Jun 2025 it was -$1.5 million, marking a year-over-year increase of 5634.41%. This contributed to the annual value of -$689199.0 for FY2024, which is 9282.91% up from last year.
  • Per Mainz Biomed's latest filing, its Net Cash Flow stood at -$1.5 million for Q4 2023, which was up 6999.63% from -$2.0 million recorded in Q3 2023.
  • Mainz Biomed's Net Cash Flow's 5-year high stood at $21.3 million during Q1 2022, with a 5-year trough of -$6.3 million in Q1 2023.